Microbiota-derived short-chain fatty acids may participate in post-stroke depression by regulating host's lipid metabolism DOI
Wenxia Jiang, Jianjun Chen, Lei Gong

et al.

Journal of Psychiatric Research, Journal Year: 2023, Volume and Issue: 161, P. 426 - 434

Published: April 4, 2023

Language: Английский

Gut liver brain axis in diseases: the implications for therapeutic interventions DOI Creative Commons

Mengyao Yan,

Shuli Man,

Benyue Sun

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Dec. 6, 2023

Gut-liver-brain axis is a three-way highway of information interaction system among the gastrointestinal tract, liver, and nervous systems. In past few decades, breakthrough progress has been made in gut liver brain axis, mainly through understanding its formation mechanism increasing treatment strategies. this review, we discuss various complex networks including barrier permeability, hormones, microbial metabolites, vagus nerve, neurotransmitters, immunity, toxic β-amyloid (Aβ) metabolism, epigenetic regulation gut-liver-brain axis. Some therapies containing antibiotics, probiotics, prebiotics, synbiotics, fecal microbiota transplantation (FMT), polyphenols, low FODMAP diet nanotechnology application regulate Besides, some special treatments targeting gut-liver include farnesoid X receptor (FXR) agonists, takeda G protein-coupled 5 (TGR5) glucagon-like peptide-1 (GLP-1) antagonists fibroblast growth factor 19 (FGF19) analogs. Targeting gut-brain embraces cognitive behavioral therapy (CBT), antidepressants tryptophan metabolism-related therapies. liver-brain contains Aβ future, better interactions will promote development novel preventative strategies discovery precise therapeutic targets multiple diseases.

Language: Английский

Citations

86

Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes DOI Creative Commons
Susanna Longo, Stefano Rizza, Massimo Federici

et al.

Acta Diabetologica, Journal Year: 2023, Volume and Issue: 60(8), P. 1007 - 1017

Published: April 14, 2023

Abstract Aims The purpose of this review is to explore the interconnected pathways microbiota-gut-brain axis (MGBA), focusing on roles vagus nerve and glucagon like peptide-1 in appetite control, development obesity diabetes. Methods Type 2 diabetes mellitus (T2DM) are metabolic disorders whose prevalence has significantly increased recent decades expected increase every year, pandemic proportions. These two pathologies often coexist have substantial public health implications. term “diabesity” defines pathophysiological connection between overweight T2DM. gut microbiota affects many aspects host. Beyond regulation intestinal functions activation immune responses, plays a role central nervous system (i.e., mood, psychiatric conditions associated with stress memory) regulator metabolism appetite. Results MGBA involves such as autonomic enteric systems, hypothalamic– pituitary–adrenal axis, system, enteroendocrine cells, microbial metabolites. Notably, an essential eating behavior by modulating learning nutritional preferences. Conclusions Because its cell-mediated interaction microbiota, may provide potential pathway through which microorganisms influence host feeding control physiological pathological conditions.

Language: Английский

Citations

70

cAMP-PKA cascade: An outdated topic for depression? DOI Open Access
Feng Gao, Shaojie Yang, Juan Wang

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2022, Volume and Issue: 150, P. 113030 - 113030

Published: April 26, 2022

Depression is a common neuropsychiatric disorder characterized by persistent depressed mood and causes serious socioeconomic burden worldwide. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, deficiency monoamine transmitters, neuroinflammation abnormalities gut flora are strongly associated with onset depression. The cyclic AMP (cAMP)/protein kinase A (PKA) cascade, major cross-species cellular signaling pathway, supposed as important player regulator depression controlling synaptic plasticity, cytokinesis, transcriptional regulation HPA axis. In central nervous system, cAMP-PKA cascade can dynamically shape neural circuits enhancing affect K+ channels phosphorylating Kir4.1, thereby regulating neuronal excitation. reduction affects excitation well ultimately leading to pathological outcome depression, while activation would provide rapid antidepressant effect. this review, we proposed reconsider function especially in Local or indirect PKA through adjusting anchor proteins new idea for acute treatment

Language: Английский

Citations

53

The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights DOI Open Access
Giuseppe Marano, Marianna Mazza, Francesco Maria Lisci

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(6), P. 1496 - 1496

Published: March 20, 2023

There is growing interest in the role that intestinal microbiota and related autoimmune processes may have genesis presentation of some psychiatric diseases. An alteration communication microbiota-gut-brain axis, which constitutes a communicative model between central nervous system (CNS) gastro-enteric tract, has been identified as one possible causes The purpose this narrative review to describe evidence supporting gut diseases impact diet on mental health. Change composition could determine an increase permeability barrier, leading cytokine storm. This trigger systemic inflammatory activation immune response: series events repercussions release neurotransmitters, altering activity hypothalamic-pituitary-adrenal reducing presence trophic brain factors. Although disorders seem be connected, more effort needed understand potential causative mechanisms underlying interactions these systems.

Language: Английский

Citations

41

The Role of Probiotics and Their Metabolites in the Treatment of Depression DOI Creative Commons
Monika Elżbieta Jach, Anna Serefko, Aleksandra Szopa

et al.

Molecules, Journal Year: 2023, Volume and Issue: 28(7), P. 3213 - 3213

Published: April 4, 2023

Depression is a common and complex mental emotional disorder that causes disability, morbidity, quite often mortality around the world. closely related to several physical metabolic conditions causing depression. Studies have indicated there relationship between intestinal microbiota brain, known as gut–brain axis. While this microbiota–gut–brain connection disturbed, dysfunctions of immune system, endocrine gastrointestinal tract occur. Numerous studies show dysbiosis characterized by abnormal dysfunction axis could be direct cause disorders. Traditional treatment depression includes psychotherapy pharmacotherapy, it mainly targets brain. However, restoration functions via using probiotics, their metabolites, prebiotics, healthy diet may alleviate depressive symptoms. Administration probiotics labeled psychobiotics metabolites metabiotics, especially an adjuvant antidepressants, improves It new approach prevention, management, illnesses, particularly major For effectiveness antidepressant therapy, should administered at dose higher than 1 billion CFU/day for least 8 weeks.

Language: Английский

Citations

31

Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats DOI

Mengnan Huang,

Yuanyuan He, Lin Tian

et al.

Journal of Affective Disorders, Journal Year: 2023, Volume and Issue: 325, P. 141 - 150

Published: Jan. 5, 2023

Language: Английский

Citations

30

Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration DOI Creative Commons

Nasir Uddin Mahbub,

Md Minarul Islam, Seong‐Tshool Hong

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14

Published: Feb. 16, 2024

Abnormal behavior of α-synuclein and prion proteins is the hallmark Parkinson’s disease (PD) illnesses, respectively, being complex neurological disorders. A primary cause protein aggregation, brain injury, cognitive loss in illnesses misfolding normal cellular (PrP C ) into an infectious form Sc ). Aggregation causes disruptions processes (PD), leading to dopamine-producing neurons motor symptoms. Alteration composition or activity gut microbes may weaken intestinal barrier make it possible for prions go from brain. The gut-brain axis linked neuroinflammation; metabolites produced by microbiota affect aggregation α-synuclein, regulate inflammation immunological responses, influence course neurotoxicity proteins, even if their targets are distinct proteins. This thorough analysis explores interactions that exist between neurodegenerative particularly involvement microbiota, a collection bacteria, archaea, fungi, viruses etc., various becoming increasingly recognized. microbiome influences neuroinflammation, neurotransmitter synthesis, mitochondrial function, integrity through axis, which contributes development progression disease. review delves molecular mechanisms underlie these relationships, emphasizing effects microbial such as bacterial lipopolysaccharides (LPS), short-chain fatty acids (SCFAs) regulating functioning. Additionally, looks at how environmental dietary decisions whether they could be risk factors illnesses. study concludes highlighting critical role plays It also provides promising direction future research treatment approaches. People afflicted difficult ailments find hope new preventive therapeutic approaches diseases better understood.

Language: Английский

Citations

15

Gut microbes in central nervous system development and related disorders DOI Creative Commons

Yumeng Gan,

Yao Chen, Huijie Zhong

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 14

Published: Jan. 26, 2024

The association between gut microbiota and central nervous system (CNS) development has garnered significant research attention in recent years. Evidence suggests bidirectional communication the CNS through brain-gut axis. As a long complex process, is highly susceptible to both endogenous exogenous factors. impacts by regulating neurogenesis, myelination, glial cell function, synaptic pruning, blood-brain barrier permeability, with implication various disorders. This review outlines relationship stages of (prenatal postnatal), emphasizing integral role microbes. Furthermore, explores implications neurodevelopmental disorders, such as autism spectrum disorder, Rett syndrome, Angelman offering insights into early detection, prompt intervention, innovative treatments.

Language: Английский

Citations

13

Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review DOI Creative Commons

Kirti Garg,

M. Hasan Mohajeri

Brain Research Bulletin, Journal Year: 2024, Volume and Issue: 207, P. 110883 - 110883

Published: Jan. 18, 2024

The link between drug-induced dysbiosis and its influence on brain diseases through gut-residing bacteria their metabolites, named the microbiota-gut-brain axis (MGBA), remains largely unexplored. This review investigates effects of commonly prescribed drugs (metformin, statins, proton-pump-inhibitors, NSAIDs, anti-depressants) gut microbiota, comparing findings with altered bacterial populations in major (depression, multiple sclerosis, Parkinson's Alzheimer's). report aims to explore whether can development progression via MGBA. Central indicate that all explored induce dysbiosis. These patterns were associated disorders. varied across different taxa, possibly mediated by direct or metabolites. Each drug induced both positive negative changes abundance bacteria, indicating a counterbalancing effect. Moreover, above-mentioned exhibited similar effects, suggesting they may counteract enhance each other's when taken together comorbid patients. In conclusion, interplay species abundances have greater impact than individual strains. Future research is needed better understand implications for disease pathogenesis, potential develop more effective therapeutic options patients brain-related diseases.

Language: Английский

Citations

11

The Role of the Gut Microbiota in Neurodegenerative Diseases DOI Creative Commons

Arshilin Philip Mani,

Balamuralikrishnan Balasubramanian,

Linsha A. Mali

et al.

Microbiology Research, Journal Year: 2024, Volume and Issue: 15(2), P. 489 - 507

Published: April 5, 2024

The human gut has a rich and dynamic microbial population that plays an important role in many physiological activities. This review explores the complex interaction between microbiota health, with emphasis on its effect neurodegenerative illnesses. makeup of microbiome impact brain function through gut–brain axis is highlighted. Dysbiosis, characterized by changes microbiota’s composition, been linked to development diseases such as Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis. A Bidirectional communication stomach takes place via variety channels, including neurotransmitters metabolites generated bacteria. We investigate processes which dysbiosis causes neuroinflammation, oxidative stress, neuronal damage, drive disease development. Potential therapeutic approaches focus microbiota, antibiotics, probiotics, prebiotics, fecal transplantation, are reviewed, promising preclinical clinical findings. Overall, this study emphasizes relevance illnesses, well need understand target gut-brain for future treatment options.

Language: Английский

Citations

10